+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
APLLTD

Alembic Pharmaceuticals Share Price

₹797.85 +8.8 (1.12%)
25.49% Gain from 52W Low

13 Oct, 2026 3:52 PM (IST)

Alembic Pharmaceuticals live price: ₹797.85. It opened at ₹787 vs previous close ₹789; intraday high/low: ₹800/₹779. The 50 & 200 DMA stand at ₹820.50/₹814.40.

Alembic Pharmaceuticals Performance

  • Today's Low
  • ₹779
  • Today's High
  • ₹800
  • 52 Week Low
  • ₹636
  • 52 Week High
  • ₹998
  • Open Price₹787
  • Previous Close₹789
  • Volume73,837
  • 50 DMA₹820.50
  • 100 DMA₹810.20
  • 200 DMA₹814.40

Alembic Pharmaceuticals Chart

Investment Returns

  • Over 1 Month -1.62%
  • Over 3 Month -4.72%
  • Over 6 Month + 10.17%
  • Over 1 Year -15.87%

Smart Investing Starts Here Start SIP with Alembic Pharmaceuticals for Steady Growth!

Invest Now

Alembic Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 22.6
  • PEG Ratio
  • 1.5
  • Market Cap Cr
  • 15,683
  • P/B Ratio
  • 2.7
  • Average True Range
  • 25
  • EPS
  • 35.3
  • Dividend Yield
  • 1.5
  • MACD Signal
  • -6.2
  • RSI
  • 40.76
  • MFI
  • 39.32

Latest Stock News Updates

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached herewith the copy of Newspaper Publication.

Alembic Pharmaceuticals Ltd - 533573 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find enclosed Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

Alembic Pharmaceuticals Ltd - 533573 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd & Others

Alembic Pharmaceuticals Financials

Alembic Pharmaceuticals Technicals

EMA & SMA

Current Price
₹797.85
+ 8.8 (1.12%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹821.70
  • 50 Day
  • ₹820.50
  • 100 Day
  • ₹810.20
  • 200 Day
  • ₹814.40

Resistance and Support

792.22 Pivot Speed
  • R3 826.80
  • R2 813.40
  • R1 805.60
  • S1 784.50
  • S2 771.10
  • S3 763.30

Alembic Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-04 Quarterly Results
2026-05-15 Audited Results & Final Dividend
2026-02-05 Quarterly Results
2025-11-04 Quarterly Results & Others To consider other business matters.
2025-08-05 Quarterly Results & Others To consider other business matters.
Date Purpose Remarks
2026-07-29 FINAL Rs.12.00 per share(600%)Final Dividend
2025-07-29 FINAL Rs.11.00 per share(550%)Final Dividend
2024-07-15 FINAL Rs.11.00 per share(550%)Final Dividend
2023-07-28 FINAL Rs.8.00 per share(400%)Final Dividend
2022-08-18 INTERIM Rs.10.00 per share(500%)Dividend (Changed Final Dividend as Interim Divided)
View Alembic Pharmaceuticals Dividend History Arrow

Alembic Pharmaceuticals Shareholding Pattern

69.87%
10%
8.73%
7.2%
4.17%

About Alembic Pharmaceuticals

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. View More
  • NSE Symbol
  • APLLTD
  • BSE Symbol
  • 533573
  • ISIN
  • INE901L01018

Similar Stocks to Alembic Pharmaceuticals

Alembic Pharmaceuticals FAQs

Alembic Pharmaceuticals share price is ₹797 As on 13 October, 2026 | 23:27

The Market Cap of Alembic Pharmaceuticals is ₹15682.8 Cr As on 13 October, 2026 | 23:27

The P/E ratio of Alembic Pharmaceuticals is 22.6 As on 13 October, 2026 | 23:27

The PB ratio of Alembic Pharmaceuticals is 2.7 As on 13 October, 2026 | 23:27

The 52 week High & Low of Alembic Pharmaceuticals is ₹998/₹635.8 respectively As on 13 October, 2026 | 23:27

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23